Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar;11(1):011304.
doi: 10.1063/5.0166848.

Mechanical forces amplify TCR mechanotransduction in T cell activation and function

Nicholas Jeffreys, Joshua M Brockman, Yunhao Zhai  1 , Donald E Ingber, David J Mooney
Affiliations
Review

Mechanical forces amplify TCR mechanotransduction in T cell activation and function

Nicholas Jeffreys et al. Appl Phys Rev. 2024 Mar.

Abstract

Adoptive T cell immunotherapies, including engineered T cell receptor (eTCR) and chimeric antigen receptor (CAR) T cell immunotherapies, have shown efficacy in treating a subset of hematologic malignancies, exhibit promise in solid tumors, and have many other potential applications, such as in fibrosis, autoimmunity, and regenerative medicine. While immunoengineering has focused on designing biomaterials to present biochemical cues to manipulate T cells ex vivo and in vivo, mechanical cues that regulate their biology have been largely underappreciated. This review highlights the contributions of mechanical force to several receptor-ligand interactions critical to T cell function, with central focus on the TCR-peptide-loaded major histocompatibility complex (pMHC). We then emphasize the role of mechanical forces in (i) allosteric strengthening of the TCR-pMHC interaction in amplifying ligand discrimination during T cell antigen recognition prior to activation and (ii) T cell interactions with the extracellular matrix. We then describe approaches to design eTCRs, CARs, and biomaterials to exploit TCR mechanosensitivity in order to potentiate T cell manufacturing and function in adoptive T cell immunotherapy.

PubMed Disclaimer

Conflict of interest statement

D.J.M. has had research sponsored by Novartis; has consulted for Medicenna, Johnson & Johnson, and IVIVA Medical; and has equity in Lyell and Attivare. N.J., J.M.B., Y.Z., and D.E.I. declare no relevant competing financial interest.

Similar articles

See all similar articles

Cited by

  • High-throughput screening for optimizing adoptive T cell therapies.
    Zhang Y, Xu Q, Gao Z, Zhang H, Xie X, Li M. Zhang Y, et al. Exp Hematol Oncol. 2024 Nov 13;13(1):113. doi: 10.1186/s40164-024-00580-w. Exp Hematol Oncol. 2024. PMID: 39538305 Free PMC article. Review.
  • Parsing digital or analog TCR performance through piconewton forces.
    Akitsu A, Kobayashi E, Feng Y, Stephens HM, Brazin KN, Masi DJ, Kirkpatrick EH, Mallis RJ, Duke-Cohan JS, Booker MA, Cinella V, Feng WW, Holliday EL, Lee JJ, Zienkiewicz KJ, Tolstorukov MY, Hwang W, Lang MJ, Reinherz EL. Akitsu A, et al. Sci Adv. 2024 Aug 16;10(33):eado4313. doi: 10.1126/sciadv.ado4313. Epub 2024 Aug 14. Sci Adv. 2024. PMID: 39141734 Free PMC article.

References

    1. Sadelain M., Rivière I., and Riddell S., “ Therapeutic T cell engineering,” Nature 545(7655), 423–431 (2017).10.1038/nature22395 - DOI - PMC - PubMed
    1. Sterner R. C. and Sterner R. M., “ CAR-T cell therapy: Current limitations and potential strategies,” Blood Cancer J. 11(4), 69 (2021).10.1038/s41408-021-00459-7 - DOI - PMC - PubMed
    1. Greenbaum U., Dumbrava E. I., Biter A. B., Haymaker C. L., and Hong D. S., “ Engineered T-cell receptor T cells for cancer immunotherapy,” Cancer Immunol. Res. 9(11), 1252–1261 (2021).10.1158/2326-6066.CIR-21-0269 - DOI - PubMed
    1. Adu-Berchie K., Obuseh F. O., and Mooney D. J., “ T cell development and function,” Rejuvenation Res. 26, 126 (2023).10.1089/rej.2023.0015 - DOI - PMC - PubMed
    1. Rushdi M., Li K., Yuan Z., Travaglino S., Grakoui A., and Zhu C., “ Mechanotransduction in T cell development, differentiation and function,” Cells 9(2), 364 (2020).10.3390/cells9020364 - DOI - PMC - PubMed